Command Palette

Search for a command to run...

Clinical Trials · NCT00993720

Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

CompletedPhase 2/Phase 3Liraglutide (Approved)
Phase
Phase 2/Phase 3
Recruitment status
Completed
Sponsor
Hvidovre University Hospital
Enrollment
30
Start date
Oct 2009
Locations
1 site, Denmark
Primary endpoint
insulin-dose
View Liraglutide compound reference